Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices

References

• McLaughlinVVArcherSLBadeschDBACCF/AHAACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationCirculation2009119162250229419332472
   PubMed Web of Science ®Google Scholar
• NairJLakshminrusimhaSUpdate on PPHN: mechanisms and treatmentSemin Perinatol2014382789124580763
   PubMed Web of Science ®Google Scholar
• Walsh-SukysMCTysonJEWrightLLPersistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomesPediatrics20001051 pt 1142010617698
   PubMed Web of Science ®Google Scholar
• SteinhornRHNeonatal pulmonary hypertensionPediatr Crit Care Med2010112 supplS79S8420216169
   PubMed Web of Science ®Google Scholar
• INOmax [package insert]Hampton, NJINO Therapeutics2015
   Google Scholar
• MillerOITangSFKeechACelermajerDSRebound pulmonary hypertension on withdrawal from inhaled nitric oxideLancet1995346896651527603160
   PubMed Web of Science ®Google Scholar
• McMullanDMBekkerJMJohengenMJInhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1Am J Physiol Heart Circ Physiol20012802H777H78511158977
   PubMed Web of Science ®Google Scholar
• WedgwoodSMcMullanDMBekkerJMFinemanJRBlackSMRole for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapyCirc Res200189435736411509453
   PubMed Web of Science ®Google Scholar
• BrownATGillespieJVMiquel-VergesFInhaled epoprostenol therapy for pulmonary hypertension: improves oxygenation index more consistently in neonates than in older childrenPulm Circ201221616622558521
   PubMedGoogle Scholar
• VaneJRBottingRMPharmacodynamic profile of prostacyclinAm J Cardiol19957533A10A
   PubMed Web of Science ®Google Scholar
• Flolan [package insert]Research Triangle Park, NCGlaxoSmithKline2014
   Google Scholar
• Ventavis [package insert]South San Francisco, CAActelion Pharmaceuticals US, Inc2013
   Google Scholar
• Orenitram [package insert]Research Triangle Park, NCUnited Therapeutics Corporation12016
   Google Scholar
• Remodulin [package insert]Research Triangle Park, NCUnited Therapeutics Corporation2014
   Google Scholar
• Tyvaso [package insert]Research Triangle Park, NCUnited Therapeutics Corporation2014
   Google Scholar
• SantakBSchreiberMKuenPLangDRadermacherPProstacyclin aerosol in an infant with pulmonary hypertensionEur J Pediatr199515432332357758525
   PubMed Web of Science ®Google Scholar
• BindlLFahnenstichHPeukertUAerosolised prostacyclin for pulmonary hypertension in neonatesArch Dis Child Fetal Neonatal Ed1994713F214F2167820721
   PubMed Web of Science ®Google Scholar
• WaxmanABZamanianRTPulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapiesAm J Cardiol20131115 suppl1A16A23040589
   PubMed Web of Science ®Google Scholar
• KellyLKPortaNFGoodmanDMCarrollCLSteinhornRHInhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxideJ Pediatr2002141683083212461501
   PubMed Web of Science ®Google Scholar
• SodittVAringCGroneckPImprovement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newbornIntensive Care Med19972312127512789470085
   PubMed Web of Science ®Google Scholar
• SPAG-2 User ManualAliso Viejo, CAValeant Pharmaceuticals2014
   Google Scholar
• Aeroneb^® Solo System Instruction ManualGalwayAerogen Ltd2014
   Google Scholar
• PachecoJArnoldHSkrupkyLWattsPMicekSTKollefMHPredictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenolRespir Care20145981178118524255157
   PubMed Web of Science ®Google Scholar
• BakerCDAbmanSHMouraniPMPulmonary hypertension in preterm infants with bronchopulmonary dysplasiaPediatr Allergy Immunol Pulmonol201427181624669351
   PubMed Web of Science ®Google Scholar
• FDA [webpage on the Internet]MAUDE adverse event report: Aerogen LTD Aeroneb Solo, Convenience, 10/pk. U.S. Food and Drug Administration Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=2577645Accessed February 16, 2015
   Google Scholar
• I-Neb AAD System User GuideChichesterPhilips Respironics2010
   Google Scholar
• Avila-AlvarezABravo-LagunaMCBronteLDDel CerroMJInhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newbornPediatr Cardiol20133482027202923143352
   PubMed Web of Science ®Google Scholar
• EhlenMWiebeBIloprost in persistent pulmonary hypertension of the newbornCardiol Young200313436136314694957
   PubMed Web of Science ®Google Scholar
• KahveciHYilmazOAvsarUZOral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newbornPediatr Pulmonol201449121205121324420987
   PubMed Web of Science ®Google Scholar
• OMRON CX3 Nebuliser Instruction ManualHoofddorpOMRON Healthcare Europe2007
   Google Scholar
• YilmazOKahveciHZeybekCCiftelMKilicOInhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertensionAm J Perinatol201431432132623797963
   PubMed Web of Science ®Google Scholar
• EifingerFSreeramNMehlerKHuenselerCKribsARothBAero-solized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot studyKlin Padiatr20082202666917710738
   PubMed Web of Science ®Google Scholar
• Tyvaso Inhalation System Instructions for UseResearch Triangle Park, NCUnited Therapeutics Corporation2013
   Google Scholar
• Alprostadil Injection [package insert]Irvine, CATeva Parenteral Medicines, Inc2009
   Google Scholar
• MeyerJTheilmeierGVan AkenHInhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failureAnesth Analg19988647537589539597
   PubMed Web of Science ®Google Scholar
• PutensenCHormannCKleinsasserAPutensen-HimmerGCardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndromeAm J Respir Crit Care Med19981576 pt 1174317479620900
   PubMed Web of Science ®Google Scholar
• SoodBGDelaney-BlackVArandaJVShankaranSAerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trialPediatr Res200456457958515295081
   PubMed Web of Science ®Google Scholar
• HEART^® Nebulizers BrochureLargo, FLIndependent Medical Associates2007
   Google Scholar
• SoodBGKeszlerMGargMEunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research NetworkInhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trialsTrials201415148625496504
   PubMedGoogle Scholar
• Joint CommissionMedical device alarm safety in hospitalsSentinal Event Alert20135013
   Google Scholar
• ShahPSOhlssonASildenafil for pulmonary hypertension in neonatesCochrane Database Syst Rev20118CD00549421833954
   PubMed Web of Science ®Google Scholar
• SiobalMSKalletRHPittetJFDescription and evaluation of a delivery system for aerosolized prostacyclinRespir Care200348874275312890294
   PubMedGoogle Scholar
• BerlinskiAWillisJRAlbuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro modelRespir Care20135871124113323107173
   PubMed Web of Science ®Google Scholar
• GardenhireDSAriAHessDMyersTRA Guide to Aerosol Delivery Devices for Respiratory Therapists3rd edIrving, TXAmerican Association for Respiratory Care2013
   Google Scholar
• WalmrathDSchneiderTSchermulyROlschewskiHGrimmingerFSeegerWDirect comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndromeAm J Respir Crit Care Med199615339919968630585
   PubMed Web of Science ®Google Scholar
• RobertsJDJrFinemanJRMorinFCIIIInhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study GroupN Engl J Med199733696056109032045
   PubMed Web of Science ®Google Scholar
• ClarkRHKueserTJWalkerMWLow-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research GroupN Engl J Med2000342746947410675427
   PubMed Web of Science ®Google Scholar
• The Neonatal Inhaled Nitric Oxide Study GroupInhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failureN Engl J Med19973369597604 published correction appears in N Engl J Med. 1997;337:4349036320
   PubMed Web of Science ®Google Scholar
• DavidsonDBarefieldESKattwinkelJInhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study GroupPediatrics19981013 pt 13253349480993
   PubMed Web of Science ®Google Scholar
• CarriedoHRhineWWithdrawal of inhaled nitric oxide from nonre-sponders after short exposureJ Perinatol200323755655814566352
   PubMedGoogle Scholar
• U.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Devices and Radiological Health [webpage on the Internet]Guidance document for premarket notification submissions for nitric oxide delivery apparatus, nitric oxide analyzer and nitrogen dioxide analyzer Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm073767.pdfAccessed December 16, 2015
   Google Scholar